Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:SYN
일자시간출처헤드라인심볼기업
2012/12/1404:56Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:SYNSynthetic Biologics Inc
2012/12/1103:38Edgar (US Regulatory)Confidential Treatment Order (ct Order)AMEX:SYNSynthetic Biologics Inc
2012/12/1103:38Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:SYNSynthetic Biologics Inc
2012/12/0706:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
2012/12/0706:35Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:SYNSynthetic Biologics Inc
2012/12/0701:56Edgar (US Regulatory)Current report filing (8-K)AMEX:SYNSynthetic Biologics Inc
2012/12/0701:56Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2012/12/0405:41Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
2012/12/0405:41Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:SYNSynthetic Biologics Inc
2012/12/0405:11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2012/12/0405:11Edgar (US Regulatory)Current report filing (8-K)AMEX:SYNSynthetic Biologics Inc
2012/12/0404:00PR Newswire (US)Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease ProgramAMEX:SYNSynthetic Biologics Inc
2012/12/0103:00PR Newswire (US)Synthetic Biologics to Present at the Fifth Annual LD MICRO Conference in Los AngelesAMEX:SYNSynthetic Biologics Inc
2012/11/1604:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
2012/11/1604:34Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:SYNSynthetic Biologics Inc
2012/11/1604:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
2012/11/1604:11Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:SYNSynthetic Biologics Inc
2012/11/1506:44Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
2012/11/1506:44Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:SYNSynthetic Biologics Inc
2012/11/1506:19Edgar (US Regulatory)Current report filing (8-K)AMEX:SYNSynthetic Biologics Inc
2012/11/1506:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2012/11/1506:02PR Newswire (US)Synthetic Biologics Reports Third Quarter 2012 Financial ResultsAMEX:SYNSynthetic Biologics Inc
2012/11/1503:58Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
2012/11/1503:58Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:SYNSynthetic Biologics Inc
2012/11/1404:57Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2012/11/1404:57Edgar (US Regulatory)Current report filing (8-K)AMEX:SYNSynthetic Biologics Inc
2012/11/1221:00PR Newswire (US)Synthetic Biologics to Acquire Clinical-Stage C. difficile Infectious Disease ProgramAMEX:SYNSynthetic Biologics Inc
2012/11/0600:55Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:SYNSynthetic Biologics Inc
2012/11/0600:55Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)AMEX:SYNSynthetic Biologics Inc
2012/11/0206:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:SYNSynthetic Biologics Inc
 검색 관련기사 보기:AMEX:SYN